Prescription drugs :
implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Realtions, Committee on Government Reform and Oversight, U.S. House of Representatives /
United States General Accounting Office.

Description

Main Author

Jagger, Sarah F.

Related Names

United States. Congress.
United States. General Accounting Office.

Language(s)

English

Published

Washington, D.C. : The Office ; [1996]

Subjects

Drug Labeling.
Medicine > Medicine / Formulae, receipts, prescriptions.
Drugs > Drugs / Prescribing > Drugs / Prescribing / United States.
Drugs > Drugs / United States > Drugs / United States / Generic substitution.
Drugs > Drugs / Labeling > Drugs / Labeling / United States.

Note

"For release ... at 10:00 a.m. September 12, 1996."
COver title.

Physical Description

8 p. ; 28 cm.

Locate a Print Version

Find in a library

Viewability